Slovak Republic
Global Fin Swe Nor Den Ger Cze Slo Pol Hun USA
  • Logo
  • Produkty
  • O nás
  • Novinky
  • Kontaktujte nás
  • Kariéra
Vyhľadávanie
Logo
  • POCT
    • QuikRead go
      • QuikRead go prístroj
      • QuikRead go easy CRP
      • QuikRead go CRP
      • QuikRead go CRP+Hb
      • QuikRead go wrCRP
      • QuikRead go wrCRP+Hb
      • QuikRead go Strep A
      • QuikRead go iFOBT
      • QuikRead go príslušenstvo
    • QuikRead
      • QuikRead 101 prístroj
      • QuikRead CRP
      • QuikRead U-ALB
      • QuikRead 101 príslušenstvo
    • microINR
      • microINR
  • Molekulárna Dx onkológia
    • MDNA Life Sciences
      • Mitomic™ Prostate Test
    • BioNTech Diagnostics
      • MammaTyper®
Logo
Zavrieť
  • Produkty
    • POCT
      • QuikRead go
        • QuikRead go prístroj
        • QuikRead go easy CRP
        • QuikRead go CRP
        • QuikRead go CRP+Hb
        • QuikRead go wrCRP
        • QuikRead go wrCRP+Hb
        • QuikRead go Strep A
        • QuikRead go iFOBT
        • QuikRead go príslušenstvo
      • QuikRead
        • QuikRead 101 prístroj
        • QuikRead CRP
        • QuikRead U-ALB
        • QuikRead 101 príslušenstvo
      • microINR
        • microINR
    • Molekulárna Dx onkológia
      • MDNA Life Sciences
        • Mitomic™ Prostate Test
      • BioNTech Diagnostics
        • MammaTyper®
  • O nás
  • Novinky
  • Kontaktujte nás
  • Kariéra

Navrhované témy

antibiotic resistance CRP point-of-care

Obľúbené produkty

QuikRead go easy CRP

QuikRead go easy CRP

MammaTyper®

MammaTyper®

Mitomic™ Prostate Test

Mitomic™ Prostate Test

Najnovšie správy

Zobraziť všetko

ECDC survey reveals European healthcare workers having good knowledge about antibiotic resistance but some gaps also exist

22. novembra 2019 | Novinky, AMR

Greetings from Aidian's launch week by our CEO Juho Himberg

19. novembra 2019 | Novinky

Orion Diagnostica is now Aidian

18. novembra 2019 | Novinky

  • Zobraziť všetko
  • Neboli nájdené žiadne výsledky
  • Loading...

Správy

ECDC survey reveals European healthcare workers having good knowledge about antibiotic resistance but some gaps also exist

22. novembra 2019 | Novinky, AMR

Greetings from Aidian's launch week by our CEO Juho Himberg

19. novembra 2019 | Novinky

Späť na všetky novinky
27. februára 2019
Novinky,
AMR

Collaborative Assessment by EUnetHTA concludes that CRP POC testing reduce antibiotic prescription for acute respiratory tract infections in primary care

The European network for Health Technology Assessment (EUnetHTA) has published a Collaborative Assessment where they evaluated the relative effectiveness and safety of using CRP POC testing to guide antibiotic prescribing in patients with acute respiratory tract infections (RTIs) in primary care settings.

QuikRead CRP, QuikRead go CRP, and QuikRead go CRP+Hb were part of the meta-analysis in systematic reviews together with 12 other CRP POC devices. The main conclusion of the report is that the use of CRP POC tests significantly reduce the antibiotic prescriptions for patients presenting in primary care with RTI compared with usual care. In addition, decreased antibiotic prescribing does not compromise patient safety in the short-term follow-up presented in the studies.

The assessment also aimed to evaluate the diagnostic test accuracy and analytical performance of the CRP tests. Due to the heterogeneity in different parameters, such as patient populations, diagnostic criteria, CRP cut-offs etc the meta-analysis of tests accuracy was not applicable. The analytical performance of the quantitative CRP POC test devices was found broadly comparable to laboratory CRP testing. However, the use of CRP POC devices in primary care may lead to greater variability of results due to less trained laboratory personnel. To minimise those risks, the assessment recommends proper training and quality assurance program to ensure analytical performance.

https://www.eunethta.eu/wp-content/uploads/2019/02/EUnetHTA_OTCA012_CRP-POCT_31012019.pdf

#TackleAMR
#testbeforeprescribing

Share
Facebook
Twitter
Email

Súbory cookie na našich webových lokalitách používame na zabezpečenie správneho fungovania webovej lokality a na uľahčenie jej optimálneho používania. Ďalším používaním našej webovej lokality vyjadrujete súhlas s používaním súborov cookie. Ďalšie informácie o súboroch cookie získate tu.

Orion Diagnostica Oy

Bělohorská 57,
169 00 Praha 6,
Česká republika

+421 944 313 888

Fakturačné adresy

IČ DPH 45769842

  • Kontaktujte nás
  • Kariéra
  • Vyhlásenie
    • Vyhlásenie o ochrane osobných údajov
    • Informačné oznámenie
    • Zásady používania súborov cookie
    • Zásady pre používanie sociálnych sietí
    • Zákaz súhlas s priamym marketingom
  • Produkty
    • QuikRead go
    • QuikRead
    • microINR
    • MDNA Life Sciences
    • BioNTech Diagnostics
Copyright © 2019 Aidian Oy